vs
Side-by-side financial comparison of Pulmonx Corp (LUNG) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
R F INDUSTRIES LTD is the larger business by last-quarter revenue ($22.7M vs $20.6M, roughly 1.1× Pulmonx Corp). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -66.3%, a 67.1% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -8.7%). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs -0.5%).
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
LUNG vs RFIL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $22.7M |
| Net Profit | $-13.7M | $173.0K |
| Gross Margin | 77.9% | 36.8% |
| Operating Margin | -40.9% | 4.0% |
| Net Margin | -66.3% | 0.8% |
| Revenue YoY | -8.7% | 22.9% |
| Net Profit YoY | 5.5% | 172.7% |
| EPS (diluted) | $-0.33 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $22.7M | ||
| Q3 25 | $21.5M | $19.8M | ||
| Q2 25 | $23.9M | $18.9M | ||
| Q1 25 | $22.5M | $19.2M | ||
| Q4 24 | $23.8M | $18.5M | ||
| Q3 24 | $20.4M | $16.8M | ||
| Q2 24 | $20.8M | $16.1M |
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $173.0K | ||
| Q3 25 | $-14.0M | $392.0K | ||
| Q2 25 | $-15.2M | $-245.0K | ||
| Q1 25 | $-14.4M | $-245.0K | ||
| Q4 24 | $-13.2M | $-238.0K | ||
| Q3 24 | $-14.1M | $-705.0K | ||
| Q2 24 | $-15.3M | $-4.3M |
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | 36.8% | ||
| Q3 25 | 74.7% | 34.0% | ||
| Q2 25 | 72.1% | 31.5% | ||
| Q1 25 | 72.5% | 29.8% | ||
| Q4 24 | 74.0% | 31.3% | ||
| Q3 24 | 73.7% | 29.5% | ||
| Q2 24 | 73.7% | 29.9% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | 4.0% | ||
| Q3 25 | -66.9% | 3.6% | ||
| Q2 25 | -62.0% | 0.6% | ||
| Q1 25 | -64.6% | 0.3% | ||
| Q4 24 | -56.5% | 0.5% | ||
| Q3 24 | -69.3% | -2.5% | ||
| Q2 24 | -75.2% | -2.6% |
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | 0.8% | ||
| Q3 25 | -64.9% | 2.0% | ||
| Q2 25 | -63.6% | -1.3% | ||
| Q1 25 | -64.1% | -1.3% | ||
| Q4 24 | -55.4% | -1.3% | ||
| Q3 24 | -69.4% | -4.2% | ||
| Q2 24 | -73.7% | -26.7% |
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $0.01 | ||
| Q3 25 | $-0.34 | $0.04 | ||
| Q2 25 | $-0.38 | $-0.02 | ||
| Q1 25 | $-0.36 | $-0.02 | ||
| Q4 24 | $-0.33 | $-0.02 | ||
| Q3 24 | $-0.36 | $-0.07 | ||
| Q2 24 | $-0.39 | $-0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.6M | $5.1M |
| Total DebtLower is stronger | $37.3M | — |
| Stockholders' EquityBook value | $45.8M | $35.2M |
| Total Assets | $120.0M | $73.0M |
| Debt / EquityLower = less leverage | 0.82× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | $5.1M | ||
| Q3 25 | $76.5M | $3.0M | ||
| Q2 25 | $75.5M | $3.6M | ||
| Q1 25 | $74.6M | $1.3M | ||
| Q4 24 | $70.9M | $839.0K | ||
| Q3 24 | $63.3M | $1.8M | ||
| Q2 24 | $63.5M | $1.4M |
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | — | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $37.2M | — | ||
| Q4 24 | $37.2M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $37.2M | — |
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $35.2M | ||
| Q3 25 | $60.0M | $34.8M | ||
| Q2 25 | $69.1M | $34.2M | ||
| Q1 25 | $77.7M | $34.2M | ||
| Q4 24 | $85.8M | $34.1M | ||
| Q3 24 | $93.9M | $34.1M | ||
| Q2 24 | $101.2M | $34.6M |
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $73.0M | ||
| Q3 25 | $138.3M | $73.2M | ||
| Q2 25 | $147.2M | $72.7M | ||
| Q1 25 | $150.7M | $70.4M | ||
| Q4 24 | $162.8M | $71.0M | ||
| Q3 24 | $167.4M | $71.9M | ||
| Q2 24 | $172.6M | $72.8M |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.37× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.1M |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 9.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $2.1M | ||
| Q3 25 | $-8.2M | $-311.0K | ||
| Q2 25 | $-3.9M | $2.2M | ||
| Q1 25 | $-13.2M | $601.0K | ||
| Q4 24 | $-6.7M | $-244.0K | ||
| Q3 24 | $-7.2M | $2.4M | ||
| Q2 24 | $-5.8M | $197.0K |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $2.0M | ||
| Q3 25 | $-8.3M | $-419.0K | ||
| Q2 25 | $-4.0M | $2.2M | ||
| Q1 25 | $-13.5M | $574.0K | ||
| Q4 24 | $-6.8M | $-418.0K | ||
| Q3 24 | $-7.7M | $2.1M | ||
| Q2 24 | $-6.2M | $28.0K |
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | 9.0% | ||
| Q3 25 | -38.4% | -2.1% | ||
| Q2 25 | -16.6% | 11.4% | ||
| Q1 25 | -60.0% | 3.0% | ||
| Q4 24 | -28.8% | -2.3% | ||
| Q3 24 | -37.6% | 12.6% | ||
| Q2 24 | -30.0% | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.3% | ||
| Q3 25 | 0.4% | 0.5% | ||
| Q2 25 | 0.2% | 0.2% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 0.5% | 0.9% | ||
| Q3 24 | 2.0% | 1.5% | ||
| Q2 24 | 2.3% | 1.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUNG
Segment breakdown not available.
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
